Therapeutic applications of mesenchymal stromal cells

Seminars in Cell and Developmental Biology

Volumn 18, Issue 6, 2007, Pages 846-858

  Brooke, Gary ^a   Cook, Matthew ^a   Blair, Chris ^b   Han, Rachel ^a   Heazlewood, Celena ^a   Jones, Ben ^a   Kambouris, Melinda ^a   Kollar, Kate ^a   McTaggart, Steven ^a   Pelekanos, Rebecca ^a   Rice, Alison ^a   Rossetti, Tony ^a   Atkinson, Kerry ^a,c  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Mesenchymal stem cells; Mesenchymal stromal cells; Review; Therapeutic applications

Indexed keywords

BONE INJURY; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL TYPE; CENTRAL NERVOUS SYSTEM DISEASE; CROHN DISEASE; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; ORGAN TRANSPLANTATION; ORTHOPEDICS; OSTEOGENESIS IMPERFECTA; REVIEW; SPINE FUSION; STROMA CELL; TISSUE REGENERATION; TISSUE REPAIR;

EID: 36248959280     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2007.09.012     Document Type: Review

References (148)

1. Horwitz E., Andreef M., and Frassoni F. Mesenchymal stromal cells. Biol Blood Marrow Transplant 13 (2007) 53-57
2. Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441
3. Boquest A.C., Shahdadfar A., Fronsdal K., Sigurjonsson O., Tunheim S.H., Collas P., et al. Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell 16 (2005) 1131-1141
4. Simmons P.J., Short B., and Brouard N. The properties of prospectively isolated mesenchymal stem cells from man and mouse. American Association of Cancer Research Education Book 2006 (2006), American Association for Cancer Research p. 334-8
5. Campagnoli C., Roberts I.A., Kumar S., Bennett P.R., Bellantuono I., and Fisk N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98 (2001) 2396-2402
6. Erices A., Conget P., and Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109 (2000) 235-242
7. In't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., de Groot-Swings G.M., Claas F.H., Fibbe W.E., et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22 (2004) 1338-1345
8. Lee O.K., Kuo T.K., Chen W.M., Lee K.D., Hsieh S.L., and Chen T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103 (2004) 1669-1675
9. Wang H.S., Hung S.C., Peng S.T., Huang C.C., Wei H.M., Guo Y.J., et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22 (2004) 1330-1337
10. Yoshimura K., Shigeura T., Matsumoto D., Sato T., Takaki Y., Aiba-Kojima E., et al. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 208 (2006) 64-76
11. Schwartz R.E., Reyes M., Koodie L., Jiang Y., Blackstad M., Lund T., et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Investig 109 10 (2002) 1291-1302
12. Owen M., and Friedenstein A.J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 136 (1988) 42-60
13. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (2006) 315-317
14. Simmons P.J., Masinovsky B., Longenecker B.M., Berenson R., Torok-Storb B., and Gallatin W.M. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 80 (1992) 388-395
15. Simmons P.J., and Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78 (1991) 55-62
16. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
17. Javazon E., Tebbets J., Beggs K., Sena-Esteves M., Campagnoli C., Radu A., et al. Isolation, expansion and characterisation of murine adult bone marrow derived mesenchymal stem cells. Blood 102 (2003) 180B-181B
18. Peister A., Mellad J.A., Larson B.L., Hall B.M., Gibson L.F., and Prockop D.J. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103 (2004) 1662-1668
19. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
20. Kovacic J.C., Muller D.W., Harvey R., and Graham R.M. Update on the use of stem cells for cardiac disease. Intern Med J 35 (2005) 348-356
21. Kucia M., Reca R., Jala V.R., Dawn B., Ratajczak J., and Ratajczak M.Z. Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia 19 (2005) 1118-1127
22. Zannettino A.C., Paton S., Arthur A., Khor F., Itescu S., Gimble J.M., et al. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol (2007)
23. Shi S., and Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18 (2003) 696-704
24. Bensidhoum M., Chapel A., Francois S., Demarquay C., Mazurier C., Fouillard L., et al. Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 103 (2004) 3313-3319
25. Devine S.M., Bartholomew A.M., Mahmud N., Nelson M., Patil S., Hardy W., et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 29 (2001) 244-255
26. Wynn R.F., Hart C.A., Corradi-Perini C., O'Neill L., Evans C.A., Wraith J.E., et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104 (2004) 2643-2645
27. Chapel A., Bertho J.M., Bensidhoum M., Fouillard L., Young R.G., Frick J., et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 5 (2003) 1028-1038
28. Ortiz L.A., Gambelli F., McBride C., Gaupp D., Baddoo M., Kaminski N., et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100 (2003) 8407-8411
29. Schweitzer K.M., Drager A.M., van der Valk P., Thijsen S.F., Zevenbergen A., Theijsmeijer A.P., et al. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am J Pathol 148 (1996) 165-175
30. Kansas G.S. Selectins and their ligands: current concepts and controversies. Blood 88 (1996) 3259-3287
31. Lowe J.B. Glycosyltransferases and glycan structures contributing to the adhesive activities of L-, E- and P-selectin counter-receptors. Biochem Soc Symp (2002) 33-45
32. Middleton J., Patterson A.M., Gardner L., Schmutz C., and Ashton B.A. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 100 (2002) 3853-3860
33. Peled A., Kollet O., Ponomaryov T., Petit I., Franitza S., Grabovsky V., et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95 (2000) 3289-3296
34. Ruster B., Gottig S., Ludwig R.J., Bistrian R., Muller S., Seifried E., et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 108 (2006) 3938-3944
35. Fox J.M., Chamberlain G., Ashton B.A., and Middleton J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137 (2007) 491-502
36. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815-1822
37. Chang C.J., Yen M.L., Chen Y.C., Chien C.C., Huang H.I., Bai C.H., et al. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 24 (2006) 2466-2477
38. Jones B.L., Brooke G., Atkinson K., and McTaggart S.J. Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells. Placenta 28 (2007) 1174-1181
39. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5 (2003) 485-489
40. Meisel R., Zibert A., Laryea M., Gobel U., Daubener W., and Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103 (2004) 4619-4621
41. Devine S.M., Cobbs C., Jennings M., Bartholomew A., and Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101 (2003) 2999-3001
42. Ringden O., Uzunel M., Rasmusson I., Remberger M., Sundberg B., Lonnies H., et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81 (2006) 1390-1397
43. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
44. Amado L.C., Saliaris A.P., Schuleri K.H., St John M., Xie J.S., Cattaneo S., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102 (2005) 11474-11479
45. Itescu S., Schuster M.D., and Kocher A.A. New directions in strategies using cell therapy for heart disease. J Mol Med 81 (2003) 288-296
46. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., and Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
47. Fang B., Shi M., Liao L., Yang S., Liu Y., and Zhao R.C. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 78 (2004) 83-88
48. Murphy J.M., Fink D.J., Hunziker E.B., and Barry F.P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48 (2003) 3464-3474
49. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
50. Zhao L.-R., Duan W.-M., Reyes M., Keene C.D., Verfaillie C.M., and Low W.C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 174 (2002) 11-20
51. McLaren A. Ethical and social considerations of stem cell research. Nature 414 (2001) 129-131
52. Bonow R.O., Smaha L.A., Smith Jr. S.C., Mensah G.A., and Lenfant C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 106 (2002) 1602-1605
53. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98 (2001) 10344-10349
54. Wang J.S., Shum-Tim D., Chedrawy E., and Chiu R.C. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg 122 (2001) 699-705
55. Wang J.S., Shum-Tim D., Galipeau J., Chedrawy E., Eliopoulos N., and Chiu R.C. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120 (2000) 999-1005
56. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103 (1999) 697-705
57. Mezey E., Chandross K.J., Harta G., Maki R.A., and McKercher S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290 (2000) 1779-1782
58. Chopp M., Zhang X.H., Li Y., Wang L., Chen J., Lu D., et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 11 (2000) 3001-3005
59. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32 (2001) 1005-1011
60. Li Y., Chen J., Zhang C.L., Wang L., Lu D., Katakowski M., et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49 (2005) 407-417
61. Le Blanc K., and Pittenger M. Mesenchymal stem cells: progress toward promise. Cytotherapy 7 (2005) 36-45
62. Sordi V., Malosio M.L., Marchesi F., Mercalli A., Melzi R., Giordano T., et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106 (2005) 419-427
63. De Coppi P., Bartsch Jr. G., Siddiqui M.M., Xu T., Santos C.C., Perin L., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25 (2007) 100-106
64. Park K.S., Jung K.H., Kim S.H., Kim K.S., Choi M.R., Kim Y., et al. Functional expression of ion channels in mesenchymal stem cells derived from umbilical cord vein. Stem Cells 25 (2007) 2044-2052
65. Li G.R., Sun H., Deng X., and Lau C.P. Characterization of ionic currents in human mesenchymal stem cells from bone marrow. Stem Cells 23 (2005) 371-382
66. Tondreau T., Lagneaux L., Dejeneffe M., Massy M., Mortier C., Delforge A., et al. Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation 72 (2004) 319-326
67. Chang Y.C., Shyu W.C., Lin S.Z., and Li H. Regenerative therapy for stroke. Cell Transplant 16 (2007) 171-181
68. Tang D.Q., Cao L.Z., Burkhardt B.R., Xia C.Q., Litherland S.A., Atkinson M.A., et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 53 (2004) 1721-1732
69. Oh S.H., Muzzonigro T.M., Bae S.H., LaPlante J.M., Hatch H.M., and Petersen B.E. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest 84 (2004) 607-617
70. Choi K.S., Shin J.S., Lee J.J., Kim Y.S., Kim S.B., and Kim C.W. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun 330 (2005) 1299-1305
71. Chen L.B., Jiang X.B., and Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 10 (2004) 3016-3020
72. Lee R.H., Seo M.J., Reger R.L., Spees J.L., Pulin A.A., Olson S.D., et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA 103 (2006) 17438-17443
73. Hess D., Li L., Martin M., Sakano S., Hill D., Strutt B., et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 21 (2003) 763-770
74. Li Y., Zhang R., Qiao H., Zhang H., Wang Y., Yuan H., et al. Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells. J Cell Physiol 211 (2007) 36-44
75. Karnieli O, Izhar-Prato Y, Bulvik S, Efrat S. Generation of insulin producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 2007; in press.
76. Xu J., Lu Y., Ding F., Zhan X., Zhu M., and Wang Z. Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-murine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene. World J Surg (2007)
77. Ito T., Suzuki A., Imai E., Okabe M., and Hori M. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 12 (2001) 2625-2635
78. Kale S., Karihaloo A., Clark P.R., Kashgarian M., Krause D.S., and Cantley L.G. Bone marrow stem cells contribute to repair of the ischaemically injured renal tubule. J Clin Invest 112 (2003) 42-49
79. Lin F., Cordes K., Li L., Hood L., Couser W.G., Shankland S.J., et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischaemia-reperfusion injury in mice. J Am Soc Nephrol 14 (2003) 1188-1199
80. Duffield J.S., and Bonventre J.V. Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 68 (2005) 1956-1961
81. Herrera M.B., Bussolati B., Bruno S., Fonsato V., Romanazzi G.M., and Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14 (2004) 1035-1041
82. Morigi M., Imberti B., Zoja C., Corna D., Tomasoni S., Abbate M., et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15 (2004) 1794-1804
83. Togel F., Hu Z., Weiss K., Isaac J., Lange C., and Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289 (2005) F31-F42
84. Kunter U., Rong S., Djuric Z., Boor P., Muller-Newen G., Yu D., et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 17 (2006) 2202-2212
85. Ninichuk V., Gross O., Segerer S., Hoffmann R., Radomska E., Buchstaller A., et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 70 (2006) 121-129
86. Petersen B.E., Bowen W.C., Patrene K.D., Mars W.M., Sullivan A.K., Murase N., et al. Bone marrow as a potential source of hepatic oval cells. Science 284 (1999) 1168-1170
87. Fiegel H.C., Lange C., Kneser U., Lambrecht W., Zander A.R., Rogiers X., et al. Fetal and adult liver stem cells for liver regenerationa nd tissue engineering. J Cell Mol Med 10 (2006) 577-587
88. Cho J.H., Kim S.H., Park K.D., Jung M.C., Yang W.I., Han S.W., et al. Chondrogenic differentiation of human mesenchymal stem cells using a thermosensitive poly(N-isopropylacrylamide) and water-soluble chitosan copolymer. Biomaterials 25 (2004) 5743-5751
89. Hong S.H., Gang E.J., Jeong J.A., Ahn C., Hwang S.H., Yang I.H., Park H.K., Han H., and Kim H. In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem Biophys Res Commun 330 4 (2005) 1153-1161
90. Banas A., Teratani T., Yamamoto Y., Takeshita F., Quinn G., Okochi H., et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology (2007) 46
91. + mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 78 (2004) 83-88
92. 4-injured rats. J Hepatol 44 (2006) 742-748
93. 4- induced liver fibrosis in mice. Hepatology 40 (2004) 1304-1311
94. Zhao D.C., Lei J.X., Chen R., Yu W.H., Zhang X.M., Li S.N., et al. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 11 (2005) 3431-3440
95. Abdel Aziz M.T., Atta H.M., Mahfouz S., Fouad H.H., Roshdy N.K., Ahmed H.H., et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 40 (2007) 893-899
96. Valfre di Bonzo L., Ferrero I., Cravanzola C., Mareschi K., Rustichelli D., Novo E., et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut (2007)
97. Popp F.C., Slowik P., Eggenhofer E., Renner P., Lang S.A., Stoeltzing O., et al. No contribution of multipotent mesenchymal stromal cells to liver regeneration in a rat model of prolonged hepatic injury. Stem Cells 25 (2007) 639-645
98. Inoue S., Popp F.C., Koehl G.E., Piso P., Schlitt H.J., Geissler E.K., et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81 (2006) 1589-1595
99. Zhou H.P., Yi D.H., Yu S.Q., Sun G.C., Cui Q., Zhu H.L., et al. Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft. Transplant Proc 38 (2006) 3046-3051
100. Garcia-Olmo D., Garcia-Arranz M., Herreros D., Pascual I., Peiro C., and Rodriguez-Montes J.A. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48 (2005) 1416-1423
101. Murphy J.M., Dixon K., Beck S., Fabian D., Feldman A., and Barry F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 46 (2002) 704-713
102. Gazdag A.R., Lane J.M., Glaser D., and Forster R.A. Alternatives to autogenous bone graft: efficacy and indications. J Am Acad Orthop Surg 3 (1995) 1-8
103. Li X.Q., Stevenson S., Klein L., Davy D.T., Shaffer J.W., and Goldberg V.M. Differential patterns of incorporation and remodeling among various types of bone grafts. Acta Anat (Basel) 140 (1991) 236-244
104. Arinzeh T.L., Peter S.J., Archambault M.P., van den Bos C., Gordon S., Kraus K., et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 85-A (2003) 1927-1935
105. Bruder S.P., Kraus K.H., Goldberg V.M., and Kadiyala S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80 (1998) 985-996
106. Cui Q., Ming Xiao Z., Balian G., and Wang G.J. Comparison of lumbar spine fusion using mixed and cloned marrow cells. Spine 26 (2001) 2305-2310
107. Pereira R.F., Halford K.W., O'Hara M.D., Leeper D.B., Sokolov B.P., Pollard M.D., et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 92 (1995) 4857-4861
108. Bembi B., Parma A., Bottega M., Ceschel S., Zanatta M., Martini C., et al. Intravenous pamidronate treatment in osteogenesis imperfecta. J Pediatr 131 (1997) 622-625
109. Marini J.C., and Gerber N.L. Osteogenesis imperfecta. Rehabilitation and prospects for gene therapy. JAMA 277 (1997) 746-750
110. Pereira R.F., O'Hara M.D., Laptev A.V., Halford K.W., Pollard M.D., Class R., et al. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 95 (1998) 1142-1147
111. Horwitz E.M., Prockop D.J., Gordon P.L., Koo W.W., Fitzpatrick L.A., Neel M.D., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97 (2001) 1227-1231
112. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99 (2002) 8932-8937
113. Le Blanc K., Gotherstrom C., Ringden O., Hassan M., McMahon R., Horwitz E., et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79 (2005) 1607-1614
114. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., and Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331 (1994) 889-895
115. Wakitani S., Imoto K., Yamamoto T., Saito M., Murata N., and Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 10 (2002) 199-206
116. Wakitani S., and Yamamoto T. Response of the donor and recipient cells in mesenchymal cell transplantation to cartilage defect. Microsc Res Tech 58 (2002) 14-18
117. Augello A., Tasso R., Negrini S.M., Cancedda R., and Pennesi G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 56 (2007) 1175-1186
118. Mourcin F., Grenier N., Mayol J.F., Lataillade J.J., Sotto J.J., Herodin F., et al. Mesenchymal stem cells support expansion of in vitro irradiated CD34(+) cells in the presence of SCF, FLT3 ligand, TPO and IL3: potential application to autologous cell therapy in accidentally irradiated victims. Radiat Res 164 (2005) 1-9
119. Angelopoulou M., Novelli E., Grove J.E., Rinder H.M., Civin C., Cheng L., et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol 31 (2003) 413-420
120. Kim D.W., Chung Y.J., Kim T.G., Kim Y.L., and Oh I.H. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 103 (2004) 1941-1948
121. Maitra B., Szekely E., Gjini K., Laughlin M.J., Dennis J., Haynesworth S.E., et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33 (2004) 597-604
122. Wang J.F., Wu Y.F., Harrintong J., and McNiece I.K. Ex vivo expansions and transplantations of mouse bone marrow-derived hematopoietic stem/progenitor cells. J Zhejiang Univ Sci 5 (2004) 157-163
123. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., and Gerson S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176 (1998) 57-66
124. Koc O.N., Gerson S.L., Cooper B.W., Dyhouse S.M., Haynesworth S.E., Caplan A.I., et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18 (2000) 307-316
125. Le Blanc K., Samuelsson H., Gustafsson B., Remberger M., Sundberg B., Arvidson J., et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21 (2007) 1733-1738
126. National Marrow Donor Program. Measuring Engraftment [Internet]. Minneapolis; [updated 2005 Jun; cited 2007 Sep 10]. Available from: http://www.marrow.org/.
127. Mielcarek M., and Storb R. Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematolgoic malignancies. Cancer Treat Rev 29 (2003) 283-290
128. Appelbaum F.R. The current status of hematopoietic cell transplantation. Annu Rev Med 54 (2003) 491-512
129. Chung N.G., Jeong D.C., Park S.J., Choi B.O., Cho B., Kim H.K., et al. Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation. Int J Hematol 80 (2004) 370-376
130. Sotiropoulou P.A., Perez S.A., Salagianni M., Baxevanis C.N., and Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24 (2006) 462-471
131. Yanez R., Lamana M.L., Garcia-Castro J., Colmenero I., Ramirez M., and Bueren J.A. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 24 (2006) 2582-2591
132. Eliopoulos N., Stagg J., Lejeune L., Pommey S., and Galipeau J. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 106 (2005) 4057-4065
133. Nauta A.J., Westerhuis G., Kruisselbrink A.B., Lurvink E.G., Willemze R., and Fibbe W.E. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108 (2006) 2114-2120
134. Tisato V., Naresh K., Girldstone J., Navarrete C., and Dazzi F. Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease. Leukemia (2007)
135. Lazarus H.M., Koc O.N., Devine S.M., Curtin P., Maziarz R.T., Holland H.K., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11 (2005) 389-398
136. Ball L.M., Bernardo M.E., Roelofs H., Lankester A., Cometa A., Egeler R.M., et al. Co-transplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation. Blood (2007)
137. Trubiani O., Di Primio R., Traini T., Pizzicannella J., Scarano A., Piattelli A., et al. Morphological and cytofluorimetric analysis of adult mesenchymal stem cells expanded ex vivo from periodontal ligament. Int J Immunopathol Pharmacol 18 (2005) 213-221
138. Shih D.T., Lee D.C., Chen S.C., Tsai R.Y., Huang C.T., Tsai C.C., et al. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells 23 (2005) 1012-1020
139. Lee K.D., Kuo T.K., Whang-Peng J., Chung Y.F., Lin C.T., Chou S.H., et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40 (2004) 1275-1284
140. Kogler G., Sensken S., Airey J.A., Trapp T., Muschen M., Feldhahn N., et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200 (2004) 123-135
141. Yen B.L., Huang H.I., Chien C.C., Jui H.Y., Ko B.S., Yao M., et al. Isolation of multipotent cells from human term placenta. Stem Cells 23 (2005) 3-9
142. Bailo M., Soncini M., Vertua E., Signoroni P.B., Sanzone S., Lombardi G., et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78 (2004) 1439-1448
143. Wulf G.G., Viereck V., Hemmerlein B., Haase D., Vehmeyer K., Pukrop T., et al. Mesengenic progenitor cells derived from human placenta. Tissue Eng 10 (2004) 1136-1147
144. in't Anker P.S., Noort W.A., Kruisselbrink A.B., Scherjon S.A., Beekhuizen W., Willemze R., et al. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 31 (2003) 881-889
145. Schallmoser K., Bartmann C., Rohde E., Reinisch A., Kashofer K., Stadelmeyer E., et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47 (2007) 1436-1446
146. Kocaoemer A., Kern S., Kluter H., and Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25 (2007) 1270-1278
147. Battula V.L., Bareiss P.M., Treml S., Conrad S., Albert I., Hojak S., et al. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75 (2007) 279-291
148. Haack-Sorensen M., Bindslev L., Mortensen S., Friis T., and Kastrup J. The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use. Cytotherapy 9 (2007) 328-337